Search tips
Search criteria 


Logo of jexpmedHomeThe Rockefeller University PressEditorsContactInstructions for AuthorsThis issue
J Exp Med. 1987 July 1; 166(1): 283–288.
PMCID: PMC2188632

In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule


We have studied the interaction of HLA class I antigens with alloreactive cytotoxic T lymphocytes and monoclonal antibodies using site-directed mutagenesis and expression of an HLA-Aw68.1 gene. Two mutants containing distinct substitutions at polymorphic residues near the NH2-terminal end of the alpha 2 domain were made. One mutant with substitutions at positions 95 and 97 corresponding to residues found in HLA-A2.1 showed no alterations in binding of HLA-Aw68- or HLA-A2- specific monoclonal antibodies, but was reactive with some HLA-A2- specific CTL clones. A second mutant, in which glycine at position 107 was replaced with tryptophan found at that position in HLA-A2.1, was recognized by HLA-A2-specific CTL clones and HLA-A2, Aw69-specific monoclonal antibodies. Thus, substitution of a single amino acid residue at position 107 of the HLA-Aw68.1 molecule generates an allospecific determinant shared with HLA-A2.1 and recognized by both B and T lymphocytes.

Full Text

The Full Text of this article is available as a PDF (375K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Zinkernagel RM, Doherty PC. MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol. 1979;27:51–177. [PubMed]
  • Nairn R, Yamaga K, Nathenson SG. Biochemistry of the gene products from murine MHC mutants. Annu Rev Genet. 1980;14:241–277. [PubMed]
  • De Waal LP, Nathenson SG, Melief CJ. Direct demonstration that cytotoxic T lymphocytes recognize conformational determinants and not primary amino acid sequences. J Exp Med. 1983 Nov 1;158(5):1720–1726. [PMC free article] [PubMed]
  • Lopez de Castro JA, Barbosa JA, Krangel MS, Biro PA, Strominger JL. Structural analysis of the functional sites of class I HLA antigens. Immunol Rev. 1985 Jul;85:149–168. [PubMed]
  • Ware CF, Krangel MS, Pious D, Burakoff SJ, Strominger JL. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line. J Immunol. 1983 Sep;131(3):1312–1317. [PubMed]
  • Holmes N, Parham P. Exon shuffling in vivo can generate novel HLA class I molecules. EMBO J. 1985 Nov;4(11):2849–2854. [PubMed]
  • Parham P, Clayberger C, Zorn SL, Ludwig DS, Schoolnik GK, Krensky AM. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the alpha 2 domain of HLA-A2. Nature. 1987 Feb 12;325(6105):625–628. [PubMed]
  • Zoller MJ, Smith M. Oligonucleotide-directed mutagenesis using M13-derived vectors: an efficient and general procedure for the production of point mutations in any fragment of DNA. Nucleic Acids Res. 1982 Oct 25;10(20):6487–6500. [PMC free article] [PubMed]
  • Sugden B, Marsh K, Yates J. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Mol Cell Biol. 1985 Feb;5(2):410–413. [PMC free article] [PubMed]
  • Chu G, Hayakawa H, Berg P. Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res. 1987 Feb 11;15(3):1311–1326. [PMC free article] [PubMed]
  • Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P. NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol. 1987 Mar 15;138(6):1657–1659. [PubMed]
  • Parham P, Androlewicz MJ, Brodsky FM, Holmes NJ, Ways JP. Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens. J Immunol Methods. 1982 Sep 17;53(2):133–173. [PubMed]
  • Clayberger C, Holmes N, Wang PL, Koller TD, Parham P, Krensky AM. Determinants recognized by human cytotoxic T cells on a natural hybrid class I HLA molecule. J Exp Med. 1985 Nov 1;162(5):1709–1714. [PMC free article] [PubMed]
  • Layet C, Kahn-Perles B, Pontarotti P, Ferrier P, Sire J, Lemonnier FA. Creation of an HLA-A2/HLA-Aw69 alloantigenic determinant on an HLA-A3 molecule by site-directed mutagenesis. J Immunol. 1987 Apr 1;138(7):2197–2201. [PubMed]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press